Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR TKI therapy in 155 patients with EGFR mutant Lung Cancers

Antzeko izenburuak

• Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
  nork: Oxnard, Geoffrey R., et al.
  Argitaratua: (2010)
• Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
  nork: Oxnard, Geoffrey R., et al.
  Argitaratua: (2011)
• Incidence of EGFR Exon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas
  nork: D'Angelo, Sandra P., et al.
  Argitaratua: (2011)
• Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers
  nork: Offin, Michael, et al.
  Argitaratua: (2018)
• Acquired Resistance to EGFR Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with EGFR-Mutant Lung Adenocarcinoma
  nork: Bean, James, et al.
  Argitaratua: (2008)